HomeSXTC • NASDAQ
China SXT Pharmaceuticals Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 494.46K | 29.54% |
Operating expense | -3.50M | -257.31% |
Net income | 3.30M | 248.59% |
Net profit margin | 667.16 | 214.70% |
Earnings per share | — | — |
EBITDA | 3.68M | 285.44% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.07M | -30.50% |
Total assets | 23.13M | -21.75% |
Total liabilities | 9.20M | -38.12% |
Total equity | 13.93M | — |
Shares outstanding | 434.51K | — |
Price to book | 0.05 | — |
Return on assets | 39.22% | — |
Return on capital | 51.46% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 3.30M | 248.59% |
Cash from operations | -674.24K | -387.91% |
Cash from investing | 3.39K | 113.14% |
Cash from financing | 918.65K | -86.89% |
Net change in cash | 306.08K | -95.75% |
Free cash flow | 2.46M | 320.46% |
Previous close
$2.40
Day range
$2.33 - $2.61
Year range
$2.33 - $26.96
Market cap
1.77M USD
Avg Volume
222.69K
P/E ratio
0.06
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Website
Employees
75
